SUBSCRIBE
SUBSCRIBE

Johnson & Johnson Withdraws Simponi in Germany Amid Mounting Product Recalls

February 22, 2011 | 
1 min read
Bloomberg -- Johnson & Johnson recalled batches of its Simponi arthritis treatment in Germany and withheld shipments that will cause shortages in Europe, adding to glitches that cost the company more than $900 million last year.
Europe
Johnson & Johnson Family of Companies
MORE ON THIS TOPIC
A man and woman on opposite edges of a large chat bubble
Insights
Golden Triangle still dominates, but talent and capital gaps slow biotech growth
July 1, 2026
 · 
3 min read
 · 
Jennifer C. Smith-Parker
Insights
The Golden Triangle and the gaps: Rethinking UK biotech
June 25, 2026
 · 
1 min read
 · 
Jennifer C. Smith-Parker
A 3D rendering of an old, simple arch bridge connecting two groups of stacked gold coins. It represents financial support, fund flow, investment, or bridging a monetary gap.
Insights
Beyond sunshine: Iberia’s biotech moment has arrived with developing capital networks
June 12, 2026
 · 
4 min read
 · 
Jennifer C. Smith-Parker
Insights
Portugal, Spain and the new biotech frontier
June 11, 2026
 · 
1 min read
 · 
Jennifer C. Smith-Parker